NC
FLGT icon

NinePointTwo Capital’s Fulgent Genetics FLGT Stock Holding History

NinePointTwo Capital’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7,853
Closed -$299K – 214
2022
Q3 		$299K Hold
7,853
– – 0.12% 100
2022
Q2 		$428K Sell
7,853
-1,362
-15% -$74.9K 0.15% 48
2022
Q1 		$575K Buy
+9,215
New +$607K 0.16% 33

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

NinePointTwo Capital's FLGT Position: Q4 2022 in Review

NinePointTwo Capital sold out of Fulgent Genetics (FLGT) in Q4 2022, closing a stake of 7,853 shares — an estimated $299K sold.

NinePointTwo Capital first reported a position in FLGT in Q1 2022 and held it in 3 quarters. The position peaked at $575K in Q1 2022. 224 funds tracked by Wall St. Rank hold FLGT as of Q4 2022.

  • NinePointTwo Capital reported no remaining Fulgent Genetics position as of Q4 2022 after selling out during the quarter.
  • NinePointTwo Capital sold 7,853 Fulgent Genetics shares in Q4 2022, an estimated $299K.
  • NinePointTwo Capital first reported a position in Fulgent Genetics in Q1 2022 and held it in 3 quarters.
  • NinePointTwo Capital's Fulgent Genetics position peaked at $575K in Q1 2022.
  • 224 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2022.

Based on NinePointTwo Capital's 13F filing for Q4 2022, filed 14 Feb 2023.